Consultant: PIRAEUS BANK S.A.
The BoD of EUROMEDICA S.A. MEDICAL SERVICES (hereinafter the "Company") hereby notifies shareholders of the following:
1. The Extraordinary General Meeting of Shareholders on 30/06/2007 has decided on the increase in the Company's Share Capital by euro 11,625,000, with the issuance of 7,500,000 new common registered shares having a nominal value of euro 1.55 each, through the payment of cash and the partial abolition of the pre-emption rights of older shareholders. The above shares were sold to AXON HOLDINGS S.A. and HEALTHCARE INVESTORS (GREECE) L.L.C. The acquisition price of the new shares amounts to euro 8.00 per share. Following the above increase, the Company's share capital amounts to fifty-eight million, seven hundred and fifty-four thousand, eight hundred and fifty euros and twenty five cents (euro 58,754,850.25) divided into 37,906,355 common registered shares with a nominal value of one euro and fifty-five cents (euro 1.55) each. The overall income from the issuance amounted to euro 60,000,000.00. The difference arising from the issuance price and nominal value of each share, amounting to a total of euro 48,375,000.00, shall -in accordance with the law and articles of association- be credited to the following account: "Reserves from the issuance of shares above par".
2. Decision no. K2-10628 (OIK) of the Minister of Development, by means of which the increase in share capital through cash payment was approved, was filed with the Companies' Register on 11/07/2007.
3. At its meeting held on 23/08/2007, the Board of Directors of the Capital Market Commission approved the content of the Prospectus, which is available on the company website (http://www.euromedica.gr/enimerotika%20deltia%20trechon%20etos-en.html), as well as on the websites of the Athens Stock Exchange (www.ase.gr) and the Capital Market Commission (www.hcmc.gr).
4. At its meeting held on 23/08/2007, the Athens Stock Exchange (ASE) approved the listing of 7,500,000 new common registered shares resulting from the increase in share capital.
5. As of 28/08/2007 the company's shares shall be traded on the ASE at an adjusted price, which shall be set in accordance with the Athens Stock Exchange Regulation, as currently in force. It is hereby certified that on the commencement of trading the new shares shall be credited to the share and securities accounts of shareholders in the Dematerialised Securities System (DSS).
6. The new shares that shall arise from the current increase shall be in dematerialised form and shall be entitled to a dividend from the profits of the 2007 fiscal year.
7. For further information shareholders can contact the Company's Shareholders' Help Desk (tel.: +30 210-6742901).